LAZIROS 25mg/ml powder for suspension for injection STADA
azacitidine Indicated for: myelodysplastic syndromes; acute myeloid leukemia
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
letter L · page 11
azacitidine Indicated for: myelodysplastic syndromes; acute myeloid leukemia
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
sodium chromoglycate Indicated for: allergic rhinitis; urticaria
S01GX01 Sensory organs | Decongestants and antiallergics | Other antiallergics
chlormethine Indicated for: cancer
L01AA05 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
demeclocycline + triamcinolone Indicated for: inflammatory dermatoses
demeclocycline + triamcinolone Indicated for: inflammatory dermatoses
bendamustine Indicated for: hematologic malignancies
L01AA09 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
levomethadone Indicated for: severe pain; opioid dependence
N07BC05 Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence
levomethadone Indicated for: severe pain; opioid dependence
N07BC05 Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence
leflunomide Indicated for: rheumatoid arthritis
leflunomide Indicated for: rheumatoid arthritis
leflunomide Indicated for: rheumatoid arthritis
leflunomide Indicated for: rheumatoid arthritis
leflunomide Indicated for: rheumatoid arthritis
leflunomide Indicated for: rheumatoid arthritis
leflunomide Indicated for: rheumatoid arthritis
leflunomide Indicated for: rheumatoid arthritis
leflunomide Indicated for: rheumatoid arthritis
leflunomide Indicated for: rheumatoid arthritis
leflunomide Indicated for: rheumatoid arthritis